| Product Code: ETC071563 | Publication Date: Jun 2023 | Updated Date: Jun 2026 | Product Type: Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 |
The India Infectious Disease Rapid Diagnostic Testing Market was estimated at USD 1064 Million in 2025 and is projected to reach USD 1517 Million by 2032, growing at a CAGR of 5.2% from 2026 to 2032. This robust growth trajectory is propelled by increased government initiatives and private sector investments aimed at enhancing public health through better management of infectious diseases. The rising prevalence of diseases such as HIV/AIDS, malaria, and tuberculosis further contributes to the growing demand for rapid testing kits across the nation.
This graph highlights how the India Infectious Disease Rapid Diagnostic Testing Market has steadily grown over the years, supported by major growth factors.

The table below presents the year‑wise growth rates along with the key drivers influencing the market
| Year | Growth Rate | Major Drivers |
| 2021 | -3.6% | Increasing adoption of advanced technologies |
| 2022 | 9.3% | Expansion of manufacturing activities |
| 2023 | 7.9% | Rapid growth in telecom and data center sectors |
| 2024 | 7.3% | Growing renewable energy integration projects |
| 2025 | 7.2% | Growing urbanization and commercial development |
| 2026 | 7.5% | Expansion of manufacturing activities |
| 2027 | 6.5% | Increasing industrial infrastructure investments |
| 2028 | 6.2% | Government infrastructure modernization initiatives |
| 2029 | 6.3% | Growing renewable energy integration projects |
| 2030 | 6.1% | Expansion of transportation and logistics networks |
| 2031 | 6.3% | Expansion of manufacturing activities |
| 2032 | 6.1% | Expansion of transportation and logistics networks |
Note - Market size estimations and growth projections presented in this report are based on 6Wresearch’s advanced forecasting approach, validated with industry datasets as of June 2026.
In recent years, the market has seen accelerated momentum fueled by heightened awareness and infrastructural improvements in healthcare. As the population becomes more health-conscious, the adoption of point-of-care diagnostic tests, particularly in the wake of the COVID-19 pandemic, has surged dramatically. However, despite this recent growth, the future landscape poses challenges that could temper expansion efforts.
Looking ahead, the demand for rapid diagnostic tests is expected to be sustained, driven by government initiatives and increasing public awareness about the benefits of early diagnosis and treatment. Additionally, the evolution of technology and the introduction of innovative products are set to reshape the market dynamics, offering both challenges and opportunities.
Despite the optimism surrounding the India Infectious Disease Rapid Diagnostic Testing Market, several restraints impede progress. One significant barrier is the high cost associated with advanced rapid diagnostic tests, particularly molecular-based assays, which may limit accessibility for some healthcare facilities. Additionally, a shortage of technical expertise and skilled personnel necessary for operating complex diagnostic instruments hampers the market's growth potential. Poor access to quality medical care, especially in rural regions, further constrains the widespread adoption of these innovative testing solutions.
The market is witnessing rapid technological advances, with the introduction of multiplexing assays capable of detecting multiple pathogens from a single sample. There is a notable shift towards personalized medicine and home healthcare monitoring devices, which are becoming increasingly appealing. Furthermore, the demand for greater accuracy in point-of-care tests is driving the innovation of novel reagents, enhancing overall testing reliability. The growing preference for e-commerce platforms for purchasing diagnostics reflects changing consumer behaviors that favor convenience and accessibility.
With the market poised for considerable growth, ample opportunities exist for investment in research and development of advanced rapid diagnostic tests. Companies focusing on creating affordable solutions while ensuring high accuracy stand to gain significantly. Additionally, the expansion of telemedicine and remote monitoring systems opens avenues for enhanced market penetration. As the healthcare landscape evolves, the increasing emphasis on early diagnosis and preventative care will create a ripe environment for innovative diagnostic solutions.
The Indian government has been proactive in launching initiatives aimed at improving public health and controlling infectious diseases. Enhanced funding for healthcare infrastructure, public awareness campaigns, and incentives for developing rapid diagnostic technologies underscore the government's commitment. Furthermore, collaborations with international organizations aim to bolster the country's capabilities in disease management and provide essential training for medical personnel, ultimately leading to better health outcomes.
Looking towards 2026-2032, the India Infectious Disease Rapid Diagnostic Testing Market is likely to evolve significantly, characterized by heightened demand for rapid and accurate testing solutions. The convergence of advanced technologies and an increasing emphasis on healthcare accessibility will play critical roles in shaping the market landscape. As public health awareness continues to grow, driven by both government and private sector efforts, the stage is set for sustainable growth and increased investment in diagnostic innovations.
Recent trends indicate a strong push towards the commercialization of novel rapid diagnostic technologies, reflecting the industry's adaptive response to emerging health challenges. Companies are increasingly focused on research partnerships aimed at developing sophisticated testing solutions. Regulatory bodies are also streamlining processes for faster approval of new tests to meet growing market demands. Enhanced training programs for healthcare professionals are gaining traction, ensuring that skilled personnel are available to operate these advanced diagnostic tools effectively.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Infectious Disease Rapid Diagnostic Testing Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, 2022 & 2032F |
3.3 India Infectious Disease Rapid Diagnostic Testing Market - Industry Life Cycle |
3.4 India Infectious Disease Rapid Diagnostic Testing Market - Porter's Five Forces |
3.5 India Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume Share, By Product, 2022 & 2032F |
3.6 India Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume Share, By Technology, 2022 & 2032F |
3.7 India Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume Share, By End-users, 2022 & 2032F |
4 India Infectious Disease Rapid Diagnostic Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in India |
4.2.2 Growing awareness and demand for rapid diagnostic testing |
4.2.3 Technological advancements leading to more accurate and efficient diagnostic tests |
4.3 Market Restraints |
4.3.1 Lack of skilled healthcare professionals for conducting rapid diagnostic tests |
4.3.2 High cost associated with rapid diagnostic testing kits |
4.3.3 Regulatory challenges and approval processes for new diagnostic tests |
5 India Infectious Disease Rapid Diagnostic Testing Market Trends |
6 India Infectious Disease Rapid Diagnostic Testing Market, By Types |
6.1 India Infectious Disease Rapid Diagnostic Testing Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 India Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Product, 2022-2032F |
6.1.3 India Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Assays, Kits and Reagents, 2022-2032F |
6.1.4 India Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Instruments, 2022-2032F |
6.1.5 India Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Services and Software, 2022-2032F |
6.2 India Infectious Disease Rapid Diagnostic Testing Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 India Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Immunodiagnostics, 2022-2032F |
6.2.3 India Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Clinical Microbiology, 2022-2032F |
6.2.4 India Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By PCR, 2022-2032F |
6.2.5 India Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By INAAT, 2022-2032F |
6.2.6 India Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By DNA Sequencing and NGS, 2022-2032F |
6.2.7 India Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Other Technologies, 2022-2032F |
6.3 India Infectious Disease Rapid Diagnostic Testing Market, By End-users |
6.3.1 Overview and Analysis |
6.3.2 India Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Physician Offices, 2022-2032F |
6.3.3 India Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Reference Laboratories, 2022-2032F |
6.3.4 India Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Hospitals, 2022-2032F |
6.3.5 India Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Academic and Research Institutes, 2022-2032F |
6.3.6 India Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Others, 2022-2032F |
7 India Infectious Disease Rapid Diagnostic Testing Market Import-Export Trade Statistics |
7.1 India Infectious Disease Rapid Diagnostic Testing Market Export to Major Countries |
7.2 India Infectious Disease Rapid Diagnostic Testing Market Imports from Major Countries |
8 India Infectious Disease Rapid Diagnostic Testing Market Key Performance Indicators |
8.1 Adoption rate of rapid diagnostic testing in healthcare facilities |
8.2 Average turnaround time for obtaining test results |
8.3 Number of partnerships or collaborations between diagnostic test manufacturers and healthcare providers |
8.4 Rate of new product development and introduction in the market |
8.5 Percentage of infectious disease cases diagnosed using rapid diagnostic tests |
9 India Infectious Disease Rapid Diagnostic Testing Market - Opportunity Assessment |
9.1 India Infectious Disease Rapid Diagnostic Testing Market Opportunity Assessment, By Product, 2022 & 2032F |
9.2 India Infectious Disease Rapid Diagnostic Testing Market Opportunity Assessment, By Technology, 2022 & 2032F |
9.3 India Infectious Disease Rapid Diagnostic Testing Market Opportunity Assessment, By End-users, 2022 & 2032F |
10 India Infectious Disease Rapid Diagnostic Testing Market - Competitive Landscape |
10.1 India Infectious Disease Rapid Diagnostic Testing Market Revenue Share, By Companies, 2025 |
10.2 India Infectious Disease Rapid Diagnostic Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here